Scroll To Top

lenacapavir injection

It’s National PrEP Day! Learn the latest about HIV prevention

There are now more ways than ever — including long-acting injectables — to prevent the spread of HIV.

Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%

Gilead researchers say lenacapavir “has the potential to be one of the most impactful interventions” in the battle against HIV.

FDA approves breakthrough drug that reduces risk of contracting HIV by 96 percent

Yeztugo, generic name lenacapavir, has been approved after nearly eliminating the spread of HIV among trial patients.

CVS Health denies coverage for  breakthrough HIV drug, committing 'clear violation' of ACA

CVS Health will not cover Gilead's Yeztugo, generic name lenacapavir (LEN), citing "clinical, financial, and regulatory factors."

House Oversight Democrats demand records over RFK Jr.’s HIV program cuts

Robert Garcia and Raja Krishnamoorthi accuse HHS of dismantling life-saving HIV programs based on conspiracy theories and anti-LGBTQ+ rhetoric.

Supreme Court hands RFK Jr. new power over Americans’ health, buried in PrEP case ruling

While the justices upheld the coverage requirement for insurance companies to pay for preventive care at no cost to the patient, they also gave the HHS secretary more power.

True

Walmart and MISTR to offer free at-home HIV testing kits

A new pilot program that kicks off July 25 will offer free at-home HIV testing kits in seven Georgia Walmart stores.